OS Therapies Inc
OSTXNYSECIK 1795091HealthcareFiscal year ends Dec 31
Reports and events: 75 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-01-1719:47 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-25-002859 |
| 2025-01-1516:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-003886 |
| 2025-01-1416:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-003460 |
| 2025-01-0317:27 ET | S-1/A | Registration statement, amended | 0001213900-25-000849 |
| 2025-01-0317:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-000844 |
| 2024-12-3017:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-113561 |
| 2024-11-2716:10 ET | S-1/A | Registration statement, amended | 0001213900-24-103456 |
| 2024-11-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-099094 |
| 2024-11-1509:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098760 |
| 2024-11-1217:11 ET | S-1 | Registration statement | 0001213900-24-096912 |
| 2024-11-0117:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-093567 |
| 2024-10-2816:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-091235 |
| 2024-08-2216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-071832 |
| 2024-08-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-069622 |
| 2024-08-1416:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-069063 |
| 2024-06-1314:05 ET | S-1/A | Registration statement, amended | 0001213900-24-052373 |
| 2024-06-0715:51 ET | S-1/A | Registration statement, amended | 0001213900-24-050739 |
| 2024-05-3017:08 ET | S-1 | Registration statement | 0001213900-24-048049 |
| 2024-05-2015:43 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-045141 |
| 2024-01-2521:25 ET | S-1/A | Registration statement, amended | 0001213900-24-006228 |
| 2023-12-2215:40 ET | S-1/A | Registration statement, amended | 0001213900-23-098158 |
| 2023-05-2206:21 ET | S-1/A | Registration statement, amended | 0001213900-23-041699 |
| 2023-04-2407:11 ET | S-1/A | Registration statement, amended | 0001213900-23-031796 |
| 2023-04-1316:25 ET | S-1/A | Registration statement, amended | 0001213900-23-029526 |
| 2023-03-3116:20 ET | S-1 | Registration statement | 0001213900-23-025493 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.